Filter Results
:
(661)
Show Results For
-
All HBS Web
(661)
- People (2)
- News (210)
- Research (291)
- Events (4)
- Multimedia (12)
- Faculty Publications (177)
Show Results For
-
All HBS Web
(661)
- People (2)
- News (210)
- Research (291)
- Events (4)
- Multimedia (12)
- Faculty Publications (177)
- 29 Jan 2018
- News
B-School Bulletin: Fighting Cancer More Efficiently
- December 2014 (Revised October 2017)
- Case
Social Business at Novartis: Arogya Parivar
By: Michael E. Porter, Mark R. Kramer and David Lane
Late in 2013, Novartis CEO Joseph Jimenez was considering whether or how to deepen the company's investment in Arogya Parivar, its profitable program that sold Novartis medicines in rural India while expanding access to medicine and health information to millions of...
View Details
Keywords:
Shared Value;
India;
Kenya;
Vietnam;
Novartis;
Arogya Parivar;
Social Business;
Multinational Firms and Management;
Competitive Advantage;
Corporate Social Responsibility and Impact;
Pharmaceutical Industry;
Viet Nam;
Kenya;
India
Porter, Michael E., Mark R. Kramer, and David Lane. "Social Business at Novartis: Arogya Parivar." Harvard Business School Case 715-411, December 2014. (Revised October 2017.)
- 15 Jan 2018
- News
A Better Business Model for Fighting Cancer
- 09 Jul 2019
- Blog Post
Solving the Complexities of the Biotechnology Industry
Azita Sharif (MBA 2000) is the Founder and Chief Executive Officer of DSI- Precision Medicine Biobanking & BINDS (Bio-Informatics Network for Discovery Science). Her goal is to positively impact human and public health using...
View Details
- 09 Jan 2019
- News
Perspectives on gene editing
- Apr 12 2017
- Testimonial
Driving Daily Change
- 21 Jun 2018
- Video
KPMA HBX Live Cracking the Data Aggregation Problem - Richard Hamermesh
- 4 Jun 2010
- Other Presentation
Value-Based Health Care Delivery
This presentation draws on Michael E. Porter and Elizabeth Olmsted Teisberg: Redefining Health Care: Creating Value-Based Competition on Results, Harvard Business School Press, May 2006, and Porter, Michael E. "A Strategy for Health Care Reform," New England...
View Details
Porter, Michael E. "Value-Based Health Care Delivery." DHCS Health Care Seminar, University of California, Los Angeles and California Department of Health Care Services, Los Angeles, CA, June 4, 2010.
- 8 Jun 2010
- Other Presentation
Value-Based Health Care Delivery
This presentation draws on Michael E. Porter and Elizabeth Olmsted Teisberg: Redefining Health Care: Creating Value-Based Competition on Results, Harvard Business School Press, May 2006, and Porter, Michael E. "A Strategy for Health Care Reform," New England...
View Details
Porter, Michael E. "Value-Based Health Care Delivery." World Innovation Forum, New York City, NY, June 8, 2010.
- Video
Anand Burman
Anand Burman, Chairman of Dabur, one of India’s largest manufacturers of natural medicine and consumer products, discusses the Ayurvedic tradition behind his company’s products.
View Details
- 21 Jan 2016
- Video
2016 Precision Trials Challenge
- 09 Oct 2020
- Blog Post
4 Things To Know About the MS/MBA Biotech
Since emigrating from Syria at the age of five, I have personally experienced the uphill battle of obtaining health care coverage as a non-US citizen. My family, along with many other immigrant and low-income families, are often forced to choose between receiving care...
View Details
- 01 Nov 2019
- Video
Devi Shetty
Devi Shetty, founder of India-based Narayana Heath, discusses his motivations for becoming a heart surgeon, as well...
View Details
- June 2003 (Revised March 2008)
- Case
Schering-Plough and Genome Therapeutics: Discovering an Asthma Gene
By: Regina E. Herzlinger and Marc Aquino
Personalized medicine requires the identification of mutated genes. Schering-Plough's search for the one related to asthma requires finding families with the disease. Examines the industry that helps conduct such research, including contract research organizations.
View Details
Keywords:
Health Disorders;
Research and Development;
Genetics;
Biotechnology Industry;
Pharmaceutical Industry
Herzlinger, Regina E., and Marc Aquino. "Schering-Plough and Genome Therapeutics: Discovering an Asthma Gene." Harvard Business School Case 303-044, June 2003. (Revised March 2008.)
- 31 Oct 2019
- Video
Anand Burman
Anand Burman, Chairman of Dabur, one of India’s largest manufacturers of natural medicine and consumer products, discusses the role of the Indian diaspora in the international growth of his...
View Details
- March 2024
- Article
Medicare Price Negotiation and Pharmaceutical Innovation Following the Inflation Reduction Act
By: Matthew Vogel, Pragya Kakani, Amitabh Chandra and Rena M. Conti
The Inflation Reduction Act (IRA) requires Medicare to negotiate lower prices for some medicines with high Medicare spending. Using historical data from public and proprietary sources to apply the IRA's negotiation criteria retrospectively, we identify all drugs that...
View Details
Keywords:
Policy;
Government Legislation;
Health Care and Treatment;
Negotiation;
Price;
Pharmaceutical Industry
Vogel, Matthew, Pragya Kakani, Amitabh Chandra, and Rena M. Conti. "Medicare Price Negotiation and Pharmaceutical Innovation Following the Inflation Reduction Act." Nature Biotechnology 42, no. 3 (March 2024): 406–412.
- 02 Feb 2016
- News
HBS Launches Clinical Trials Contest
- 06 Jun 2018
- Video
Tarran Pierfelice, Blavatnik Fellow 2018-2019
- June 2002 (Revised November 2005)
- Case
Life, Death, and Property Rights: The Pharmaceutical Industry Faces AIDS in Africa
By: Debora L. Spar
In the final years of the 20th century, the world was hit by a plague of epidemic proportions--AIDS, a life-threatening disease that remained stubbornly immune to any cure or vaccine. In the developed nations of the West, AIDS was slowly brought under control through a...
View Details
Keywords:
Patents;
Health Pandemics;
Corporate Social Responsibility and Impact;
Pharmaceutical Industry;
Africa
Spar, Debora L., and Nick Bartlett. "Life, Death, and Property Rights: The Pharmaceutical Industry Faces AIDS in Africa." Harvard Business School Case 702-049, June 2002. (Revised November 2005.)
- Video
Anand Burman
Anand Burman, Chairman of Dabur, one of India’s largest manufacturers of natural medicine and consumer products, explains how his company overcame shortages of fresh herbs and plants by establishing nursery greenhouses in India and Nepal.
View Details